United Therapeutics Corporation shares owned by WEDGE Capital Management L
Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by WEDGE Capital Management L
from 13F filings
Historical chart of WEDGE Capital Management L investment in United Therapeutics Corporation
Tip: Access up to 7 years of quarterly data
All positions including United Therapeutics Corporation held by WEDGE Capital Management L consolidated in one spreadsheet with up to 7 years of data
Download as csv![Download consolidated filings csv](/static/img/csv.png)
![Download consolidated filings xlsx](/static/img/microsoft-excel.png)
Quarterly reported holdings in United Therapeutics Corporation by WEDGE Capital Management L
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-06-30 | $40M | 127k | 318.55 |
2024-03-31 | $39M | 171k | 229.72 |
2022-12-31 | $40M | 143k | 278.09 |
2022-09-30 | $35M | 166k | 209.38 |
2022-06-30 | $38M | 160k | 235.64 |
2022-03-31 | $32M | 178k | 179.41 |
2021-12-31 | $35M | 162k | 216.08 |
2021-09-30 | $29M | 158k | 184.58 |
2021-06-30 | $33M | 184k | 179.41 |
2021-03-31 | $32M | 190k | 167.27 |
2020-12-31 | $30M | 199k | 151.79 |
2020-09-30 | $26M | 256k | 101.00 |
2020-06-30 | $35M | 287k | 121.00 |
2019-03-31 | $39M | 335k | 117.37 |
2018-12-31 | $32M | 295k | 108.90 |
2018-09-30 | $35M | 270k | 127.88 |
2018-06-30 | $31M | 273k | 113.15 |
2018-03-31 | $36M | 321k | 112.36 |
2017-12-31 | $48M | 325k | 147.95 |
2017-09-30 | $1.3M | 12k | 117.17 |
2017-06-30 | $1.2M | 9.4k | 129.71 |
2017-03-31 | $1.1M | 8.1k | 135.37 |
2016-12-31 | $1.1M | 7.9k | 143.37 |
2016-09-30 | $975k | 8.3k | 118.11 |
2016-06-30 | $473k | 29k | 16.37 |
2016-03-31 | $860k | 7.7k | 111.46 |
2014-06-30 | $630k | 7.1k | 88.42 |
2014-03-31 | $322k | 3.4k | 94.01 |
2013-12-31 | $404k | 3.6k | 113.01 |
More positions owned by WEDGE Capital Management L
View all positions for WEDGE Capital Management L
Top funds holding United Therapeutics Corporation
View all funds holding United Therapeutics Corporation